Alterations of the gut microbiota may cause dysregulated mucosal immune responses
leading to the onset of inflammatory bowel diseases (IBD) in genetically susceptible hosts …

Inflammatory bowel disease (IBD) is a chronic disease with periods of exacerbation and
remission of the disease. The etiology of IBD is not fully understood. Many studies point to …

Background Aging is a natural process that an organism gradually loses its physical fitness
and functionality. Great efforts have been made to understand and intervene in this …

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by
biliary inflammation and stricturing. Exploration of the pathogenesis of PSC in light of its …

Dynamic interactions between the gastrointestinal epithelium and the mucosal immune
system normally contribute to ensuring intestinal homeostasis and optimal …

Limosilactobacillus reuteri is a microorganism with valuable probiotic qualities that has been
widely employed in humans to promote health. It is a well-studied probiotic bacterium that …

Background Faecal microbiota transplantation (FMT) has previously been explored as a
treatment for ulcerative colitis (UC) however, biomarkers that predict and/or are associated …

Fecal microbiota transplantation (FMT) describes the transfer of feces from a healthy donor
into the gut of a diseased recipient with the goal of modulating the recipient's intestinal …

The gut microbiota composition is important for nutrient metabolism, mucosal barrier
function, immunomodulation, and defense against pathogens. Alterations in the gut …

Objective To evaluate the safety and efficacy of fecal microbiota transplantation for
autoimmune diseases and autoinflammatory diseases. Methods Relevant literature was …